A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -58.02% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -53.53%. Over the past 30 days, the price of RVNC has leaped by -25.00%. And in the last five days, it has surged by 1.37%.
The market performance of Revance Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $37.98 on 05/09/23, with the lowest value for the same timeframe being $3.21, recorded on 04/26/24.
52-week price history of RVNC Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Revance Therapeutics Inc’s current trading price is -90.28% away from its 52-week high, while its distance from the 52-week low is 14.95%. The stock’s price range for this period has been between $3.21 and $37.98. The Healthcare sector company’s shares saw a trading volume of about 3.22 million for the day, which was higher than the average daily volume of 1.84 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Revance Therapeutics Inc (RVNC) has experienced a quarterly decline of -38.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 384.57M and boasts a workforce of 597 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.90, with a change in price of -3.74. Similarly, Revance Therapeutics Inc recorded 1,722,299 in trading volume during the last 100 days, posting a change of -50.34%.
RVNC Stock Stochastic Average
As of today, the raw stochastic average of Revance Therapeutics Inc over the last 50 days is at 11.03%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 27.75%. Further, the company’s Stochastic %K and %D values for the last 20 days were 13.92% and 7.42%, respectively.
